ACADIA Pharmaceuticals, Inc. (ACAD)
26.68
-0.14
(-0.50%)
USD |
NASDAQ |
Dec 11, 16:00
26.68
0.00 (0.00%)
After-Hours: 17:56
ACADIA Pharmaceuticals Research and Development Expense (TTM): 344.78M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | 100.10M |
| ADMA Biologics, Inc. | 3.776M |
| Aldeyra Therapeutics, Inc. | 35.99M |
| Amicus Therapeutics, Inc. | 142.29M |
| ANI Pharmaceuticals, Inc. | 56.05M |